Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBI-4000 15% Gel in Palmar Hyperhidrosis
NCT02682238Phase 2Completed
- Sponsor
- Botanix Pharmaceuticals
- Start
- Mar 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in palmar hyperhidrosis (PH) comparing BBI-4000 15% with Vehicle (2 arms). Primary endpoint: Number of Treatment Emergent Adverse Events by Severity at Day 42. Started Mar 2016; status: completed.
02
Drugs
sofpironium
03
Conditions
palmar hyperhidrosis (PH)
Beyond the preview
Go deeper on NCT02682238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682238.